Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Bernadette Harkin was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • May 01
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Bernadette Harkin was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Dec 24
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Bernadette Harkin was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Sep 19
Archer Materials Limited, Annual General Meeting, Nov 20, 2025 Archer Materials Limited, Annual General Meeting, Nov 20, 2025. Board Change • Aug 18
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Non-Executive Director Bernadette Harkin was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Feb 04
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Non-Executive Director Bernadette Harkin was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Dec 24
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Non-Executive Director Bernadette Harkin was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Nov 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Non-Executive Director Bernadette Harkin was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Ankündigung • Oct 18
Archer Materials Limited, Annual General Meeting, Nov 20, 2024 Archer Materials Limited, Annual General Meeting, Nov 20, 2024. Location: stone & chalk sydney scaleup hub, level 2, 477 pitt street, haymarket, 2000., Australia Ankündigung • Jul 13
Mohammad Choucair to Step Down as Chief Executive Officer of Archer Materials Limited in January 2025 Archer Materials Limited announced the departure of Dr. Mohammad Choucair as Chief Executive Officer ("CEO"). Mohammad will step down from the CEO role in January 2025 to ensure a smooth transition and handover. Mohammad retires from the Company for personal reasons. Ankündigung • Mar 15
Archer Materials Limited Designs Miniaturised Version of Biochip Biochip Graphene Field Effect Transistor Chip Archer Materials Limited has designed a miniaturised version of its Biochip graphene field effect transistor (“gFET”) chip for fabrication at a commercial foundry. The Archer Biochip contains a sensing region of which the gFET is the core component. Each gFET chip contains multiple gFETs, each of which is a transistor, which acts as a sensor. Archer has miniaturised the total chip size by redesigning the layout of the circuits creating these gFET transistors. The new miniaturised design has been sent to a foundry partner for a whole-wafer fabrication of reduced size gFET chips, which Archer intends to integrate with other parts of the Biochip technology. The new gFET chip design has been significantly reduced in size over earlier designs of 10mm x 10mm to 1.5mm x 1.5mm. It will be tested on a four-inch wafer which is expected to produce 1375 chips on it, compared to the 45 chips produced using earlier designs in previous four-inch wafer fabrication runs. The chip will be fabricated by Applied Nanolayers (“ANL”), based in the Netherlands, which has fabricated earlier designs of Archer’s gFETs (ASX ann. 14 September 2023). Independent to wafer runs at ANL, Archer has also sent gFET designs to a foundry in Spain for fabrication, with delivery anticipated within the first half of 2024 (ASX ann. 11 December 2023). Archer applies the ‘fabless’ chipmaker model by designing, researching, and developing its chips, while outsourcing manufacturing to specialised companies in the semiconductor supply chain. This includes the creation of a new miniaturised Biochip gFET chip design, sending the design for a whole wafer run in a commercial foundry, and deciding on the chip assembly and semiconductor device electronics packaging and related electrical testing. The wafer will be diced and assembled at Archer’s newly established outsourced semiconductor assembly and testing (“OSAT”) partner, AOI Electronics in Japan. The OSAT includes moulding, dicing, and lead frame design for this dedicated wafer assembly, and also device electronic shorting and related packaging testing. These new capabilities are key in advancing the Biochip development to interfacing and integration with miniaturised gFET chip sensor designs. Delivery of the packaged chips is anticipated in mid-2024. New Risk • Feb 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 39% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Revenue is less than US$5m (AU$1.8m revenue, or US$1.2m). Market cap is less than US$100m (AU$112.1m market cap, or US$73.6m). Ankündigung • Nov 02
Archer Materials Limited Demonstrates Multiplexing Readout for its Advanced Biochip Graphene Field Effect Transistor Device Archer Materials Limited has demonstrated multiplexing readout for its advanced Biochip graphene field effect transistor (gFET) device. Archer confirmed single-device multiplexing using four advanced gFETs as sensors, which were integrated into the Archer advanced Biochip platform that was announced on 14 September 2023. This is significant as Archer intends to apply its multiplexing capability in the Biochip to test for multiple diseases on a single chip at once. Archer designed and developed the new hardware and software systems to readout the signal from the four advanced gFET sensors at once on a single chip. This is a significant advance over the earlier generation of the Biochip system, which could only activate one-sensor-at-a-time. The new Biochip system with multiplexing capability also provides automated hands-free operation, as it integrates liquid handling automation and data acquisition. The software developed by Archer can display all single and time series measurements in real-time for the four gFET sensors simultaneously. Ankündigung • Oct 28
Archer Materials Limited, Annual General Meeting, Nov 29, 2023 Archer Materials Limited, Annual General Meeting, Nov 29, 2023, at 10:30 E. Australia Standard Time. Location: KPMG, Level 38, Tower Three, International Towers Sydney 300 Barangaroo Avenue Sydney New South Wales Australia Agenda: To consider he Remuneration Report for the year ended 30 June 2023; to consider Re-election of Bernadette Harkin as a Director; to consider Approval of Issues of Securities under the New Performance Rights Plan and Share Option Plan; to consider Modification of the Company's Constitution; to consider Approval of 10% additional placement capacity; to consider Renewal of proportional takeover provisions in the Constitution; and to consider other matters. New Risk • Aug 17
New major risk - Revenue size The company makes less than US$1m in revenue. Total revenue: AU$1.6m (US$1m) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 53% per year over the past 5 years. Revenue is less than US$1m (AU$1.6m revenue, or US$1m). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (2.6% increase in shares outstanding). Market cap is less than US$100m (AU$130.0m market cap, or US$83.6m). Ankündigung • Aug 01
Archer Materials Limited Further Enhances Biochip gFET Design for Advanced Sensing and Send to Commercial Foundry Partner Archer Materials Limited has developed a next generation biochip fabrication to better detect and control disease samples on a single graphene field effect transistor ("gFET") design. The gFET design also has functional surfaces and components, for both the sensor and control of the biochip platform. There is also an integration of gFET design components that allow for the real-time fine tuning and control of the electronic properties of the graphene. This has the potential advantage of biosensors that are re-usable, leading to an extended device lifetime. In addition, Archer has improved its biochip system platform testing capabilities to develop a more accurate sensor. The upgraded automated testing platform conducts both control software and readout hardware with improved efficiency. The software is also progressing towards automated data analysis, so end users can extract high quality data. This new more complex gFET design complements the proof-of-concept biosensing gFET announced on 13 July 2023. The earlier design was submitted to a commercial foundry for a Multi-Project Wafer run, with the completed devices expected to be delivered by the end of 2023. The new advanced device designs which are the subject of this announcement have now been submitted to a foundry in the Netherlands for a whole wafer run (the previous 'simpler' design was submitted to a foundry in Germany for a Multi- Project Wafer ("MPW") run). An MPW is where Archer's device design is imprinted on a small area of a wafer with the designs of other companies on the same wafer. The new more complex gFet design will be fabricated all over one, stand-alone four-inch wafer. The new advanced gFET device design and whole wafer run in a commercial foundry is an example of how Archer is now moving towards a streamlined commercialization model that closely aligns to the 'fabless' model (i.e. Archer focuses on designing and developing its chips and outsources the manufacturing to specialized foundries). The new gFET device designs and related processes form the basis of intellectual property that is 100% owned by Archer. Ankündigung • Jul 14
Archer Materials Limited Transfers Biochip Graphene Sensor Technology Design to A Commercial Fab to Verify Scalability Archer Materials Limited has completed a proof of concept biosensing graphene transistor for use in its biochip, and submitted the technology design to a commercial foundry to verify scalability. The Archer-designed gFET sensing chips will be produced by a commercial foundry, with the aim of Archer validating its design to ensure appropriate scalability for the manufacturing process. Archer expects completed runs to arrive at the end of 2023. The runs will be evaluated to test which foundry and process are best suited to Archer's technology. Archer's design and process can then be scaled to manufacture complete wafers containing the graphene-based sensors for biochip integration in collaboration with a range of different commercial foundries. Archer has, in parallel, started discussions with potential global foundry partners for initial small production runs of its graphene chip designs to evaluate the reliability of the product. The latest development follows the recent announcement on 10 March 2023 in which the Company gained electronic control of the sensitivity of its incorporated gFET devices so it can better target biomolecules. This followed Archer's early-stage biochip prototype with an integrated system platform for biosensing announced to the market on 16 November 2022, after having developed a 'wettable' gFET announced on 24 October 2022. New Risk • Jun 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 53% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (2.6% increase in shares outstanding). Revenue is less than US$5m (AU$1.6m revenue, or US$1.0m). Executive Departure • Nov 24
Independent Non-Executive Director Alice McCleary has left the company On the 24th of November, Alice McCleary's tenure as Independent Non-Executive Director ended after 14.8 years in the role. As of September 2021, Alice still personally held 3.87m shares (AU$6.7m worth at the time). Alice is the only executive to leave the company over the last 12 months. Reported Earnings • Sep 23
Full year 2021 earnings released: AU$0.009 loss per share (vs AU$0.014 loss in FY 2020) Full year 2021 results: Net loss: AU$3.33m (loss widened 19% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 173% per year, which means it is well ahead of earnings. Ankündigung • Jun 18
Baudin Minerals Pty Ltd completed the acquisition of Exploration Licenses EL 5815 and EL 5920 in Australia from Archer Materials Limited (ASX:AXE). Baudin Minerals Pty Ltd signed an agreement to acquire Exploration Licenses EL 5815 and EL 5920 in Australia from Archer Materials Limited (ASX:AXE) for AUD 3.9 million on December 22, 2020. Under the agreement, Baudin Minerals Pty Ltd shall pay AUD 0.05 million upon signing of agreement, AUD 0.1 million payable if Baudin Minerals Pty Ltd elects to proceed after the end of due diligence period and balance payable in the form of cash or shares in the relevant listed entity at the election of buyer. Baudin Minerals Pty Ltd shall also pay bonus and royalty to Archer Materials Limited. Completion is subject to satisfactory due diligence, approval from South Australian Government and listing of Baudin Minerals Pty Ltd on Stock Exchange. Completion will take place on June 30, 2021 or such other date agreed by Archer Materials Limited and the Baudin Minerals Pty Ltd. The date for Completion may be extended by Baudin Minerals Pty Ltd for three months at a time (up to December 31, 2021) by paying to Archer Materials Limited AUD 0.1 million per extension (up to a total of AUD 0.2 million). As of March 15, 2021, Baudin Minerals Pty Ltd has satisfied itself as to its due diligence enquiries and issuing a Notice to Proceed and paying the amount of AUD 0.1 million to Archer Materials Limited. Completion occurs on the earlier of the tenth business day after the cut-off date, and such other date agreed between Baudin Minerals Pty Ltd and Archer Materials Limited. As of May 21, 2021, the transaction is expected to complete by the end of September 2021.
Baudin Minerals Pty Ltd completed the acquisition of Exploration Licenses EL 5815 and EL 5920 in Australia from Archer Materials Limited (ASX:AXE) on June 18, 2021. Reported Earnings • Feb 26
First half 2021 earnings released: AU$0.028 loss per share (vs AU$0.009 loss in 1H 2020) First half 2021 results: Net loss: AU$6.41m (loss widened 261% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has increased by 111% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Feb 23
New 90-day high: AU$1.17 The company is up 127% from its price of AU$0.52 on 25 November 2020. The Australian market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 21% over the same period. Is New 90 Day High Low • Jan 20
New 90-day high: AU$0.73 The company is up 47% from its price of AU$0.50 on 23 October 2020. The Australian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 20% over the same period. Recent Insider Transactions • Oct 02
Independent Non-Executive Director recently sold AU$53k worth of stock On the 28th of September, Paul Rix sold around 100k shares on-market at roughly AU$0.53 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Sep 26
Full year earnings released - AU$0.014 loss per share Over the last 12 months the company has reported total losses of AU$2.80m, with losses widening by 61% from the prior year.